INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

AVXLANAVEX LIFE SCIENCES CORP.

CIK 0001314052

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score15
Connections4with evidence

AVXL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BS
Boenisch SandraPFO & Treasurer
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
20.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Lobbied forevidence
    FORBES-TATELDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Boenisch SandraPFO & Treasurer · Jan 9, 2026
  • ← Insider ofevidence
    Missling Christopher UDirector, President and CEO · Jan 9, 2026
9
BS
Boenisch SandraPFO & Treasurer
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A
—
25.0K sh
Sep 24, 2026
Sep 28, 2026
traded Sep 24, 2026
+4d
SEC FORM 4

Evidence

9
BS
Boenisch SandraPFO & Treasurer
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
25.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

9
BS
Boenisch SandraPFO & Treasurer
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
25.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

15
MU
Missling Christopher UDirector, President and CEO
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
125.0K sh
Jan 6, 2026Jan 9, 2026
traded Jan 6, 2026
+3dSEC FORM 4

Evidence

15
BS
Boenisch SandraPFO & Treasurer
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
12.5K sh
Jan 6, 2026Jan 9, 2026
traded Jan 6, 2026
+3dSEC FORM 4

Evidence

Lobbying

$40K reported · de-duplicated
2026 Q1 $40K via firms
  • FORBES-TATE$40K2026 Q1 · posted Aug 26, 2026 · Health issues
  • FORBES-TATE—2026 Q1 · posted Aug 26, 2026 ·

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.